Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
NCT01000493
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class
Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG:
orvepitant
OTHER:
Placebo
Sponsor
GlaxoSmithKline